Resultados de la búsqueda 341-350 of 1039 for ���������������������������������TALK:PC53���

1. Neurología - Ensayos clínicos

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

3. Neurología - Ensayos clínicos

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

4. Neurología - Ensayos clínicos

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

6. La maratón de RCP salva vidas - Mayo Clinic

   De Mayo Clinic a tu buzón. Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate the effectiveness and safety of REC-2282 in patients with progressive NF2 mutated meningiomas who have either NF2 ...